Benjamin B. Davis

1.2k total citations · 1 hit paper
17 papers, 936 citations indexed

About

Benjamin B. Davis is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Benjamin B. Davis has authored 17 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biochemistry, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in Benjamin B. Davis's work include Eicosanoids and Hypertension Pharmacology (9 papers), Hormonal Regulation and Hypertension (8 papers) and Plant biochemistry and biosynthesis (3 papers). Benjamin B. Davis is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (9 papers), Hormonal Regulation and Hypertension (8 papers) and Plant biochemistry and biosynthesis (3 papers). Benjamin B. Davis collaborates with scholars based in United States, Canada and Czechia. Benjamin B. Davis's co-authors include Matthew E. Bergman, Michael A. Phillips, Bruce D. Hammock, Christophe Morisseau, Robert H. Weiss, In-Hae Kim, Hsing-Ju Tsai, Ning Li, Nipavan Chiamvimonvat and Danyan Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and PLANT PHYSIOLOGY.

In The Last Decade

Benjamin B. Davis

17 papers receiving 924 citations

Hit Papers

Medically Useful Plant Terpenoids: Biosynthesis, Occurren... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin B. Davis United States 12 584 385 251 182 117 17 936
Mona E. Aboutabl Egypt 14 284 0.5× 181 0.5× 185 0.7× 100 0.5× 143 1.2× 32 711
Yuguang Lin Netherlands 20 160 0.3× 275 0.7× 542 2.2× 75 0.4× 80 0.7× 27 1.5k
Linda L. Gallo United States 20 202 0.3× 302 0.8× 541 2.2× 47 0.3× 93 0.8× 38 1.4k
Zafarul H. Beg United States 24 166 0.3× 218 0.6× 853 3.4× 71 0.4× 137 1.2× 35 1.7k
Marta Chataigneau France 7 74 0.1× 113 0.3× 158 0.6× 79 0.4× 45 0.4× 9 758
Ching‐jang Huang Taiwan 19 52 0.1× 337 0.9× 348 1.4× 99 0.5× 89 0.8× 31 1.0k
Kazuhiko Tsutsumi Japan 22 76 0.1× 495 1.3× 376 1.5× 53 0.3× 53 0.5× 60 1.3k
Valérie B. Schini-Kerth France 16 63 0.1× 101 0.3× 412 1.6× 100 0.5× 77 0.7× 24 1.1k
Maude Fer France 8 211 0.4× 67 0.2× 143 0.6× 75 0.4× 116 1.0× 8 470
Panchanatham Sachdanandam India 24 79 0.1× 391 1.0× 443 1.8× 67 0.4× 229 2.0× 57 1.4k

Countries citing papers authored by Benjamin B. Davis

Since Specialization
Citations

This map shows the geographic impact of Benjamin B. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin B. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin B. Davis more than expected).

Fields of papers citing papers by Benjamin B. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin B. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin B. Davis. The network helps show where Benjamin B. Davis may publish in the future.

Co-authorship network of co-authors of Benjamin B. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin B. Davis. A scholar is included among the top collaborators of Benjamin B. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin B. Davis. Benjamin B. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Duggan, Peter, et al.. (2022). Design and fabrication of an improved dynamic flow cuvette for 13CO2 labeling in Arabidopsis plants. Plant Methods. 18(1). 40–40. 5 indexed citations
2.
Bergman, Matthew E., et al.. (2022). An Arabidopsis GCMS chemical ionization technique to quantify adaptive responses in central metabolism. PLANT PHYSIOLOGY. 189(4). 2072–2090. 5 indexed citations
3.
Davis, Benjamin B., et al.. (2022). A lesion-mimic mutant of Catharanthus roseus accumulates the opioid agonist, akuammicine. Phytochemistry. 203. 113422–113422. 1 indexed citations
4.
Bergman, Matthew E., Benjamin B. Davis, & Michael A. Phillips. (2019). Medically Useful Plant Terpenoids: Biosynthesis, Occurrence, and Mechanism of Action. Molecules. 24(21). 3961–3961. 259 indexed citations breakdown →
5.
Davis, Benjamin B., et al.. (2012). Leukocytes Are Recruited through the Bronchial Circulation to the Lung in a Spontaneously Hypertensive Rat Model of COPD. PLoS ONE. 7(3). e33304–e33304. 23 indexed citations
6.
7.
Davis, Benjamin B., Amir A. Zeki, Lei Wang, Nicholas J. Kenyon, & Kent E. Pinkerton. (2012). Simvastatin Reduces Tobacco Smoke-Induced Lung Inflammation, Airway Remodeling And Abnormal Pulmonary Function Characteristic Of COPD. A1280–A1280. 1 indexed citations
8.
Davis, Benjamin B., et al.. (2012). Soluble Epoxide Hydrolase Inhibitors and Cardiovascular Diseases. Current Vascular Pharmacology. 11(1). 105–111. 16 indexed citations
9.
Wang, Zhenhe, et al.. (2012). Soluble Epoxide Hydrolase Inhibitors and Cardiovascular Diseases. Current Vascular Pharmacology. 11(1). 105–111. 19 indexed citations
10.
Davis, Benjamin B., Jun‐Yan Liu, Daniel J. Tancredi, et al.. (2011). The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment. Biochemical and Biophysical Research Communications. 410(3). 494–500. 20 indexed citations
11.
Ulu, Arzu, Benjamin B. Davis, Hsing-Ju Tsai, et al.. (2008). Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model. Journal of Cardiovascular Pharmacology. 52(4). 314–323. 107 indexed citations
12.
Xu, Danyan, Ning Li, Yuxia He, et al.. (2006). Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proceedings of the National Academy of Sciences. 103(49). 18733–18738. 203 indexed citations
13.
Davis, Benjamin B., Christophe Morisseau, John W. Newman, et al.. (2006). Attenuation of Vascular Smooth Muscle Cell Proliferation by 1-Cyclohexyl-3-dodecyl Urea Is Independent of Soluble Epoxide Hydrolase Inhibition. Journal of Pharmacology and Experimental Therapeutics. 316(2). 815–821. 26 indexed citations
14.
Yu, Zhigang, Benjamin B. Davis, Christophe Morisseau, et al.. (2004). Vascular localization of soluble epoxide hydrolase in the human kidney. American Journal of Physiology-Renal Physiology. 286(4). F720–F726. 60 indexed citations
15.
Davis, Benjamin B., Yao Dong, & Robert H. Weiss. (2003). Overexpression of p73 causes apoptosis in vascular smooth muscle cells. American Journal of Physiology-Cell Physiology. 284(1). C16–C23. 11 indexed citations
16.
Davis, Benjamin B., et al.. (2002). Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation. Proceedings of the National Academy of Sciences. 99(4). 2222–2227. 104 indexed citations
17.
Zenser, Terry V., Michael B. Mattammal, & Benjamin B. Davis. (1980). Mechanism of FANFT cooxidation by prostaglandin endoperoxide synthetase.. Journal of Pharmacology and Experimental Therapeutics. 214(2). 312–317. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026